Provincial squeeze on generic prices continues.
作者信息
Moulton Donalee
出版信息
CMAJ. 2011 Oct 4;183(14):E1049-50. doi: 10.1503/cmaj.109-3966. Epub 2011 Sep 6.
Abstract
摘要
相似文献
1
Provincial squeeze on generic prices continues.
CMAJ. 2011 Oct 4;183(14):E1049-50. doi: 10.1503/cmaj.109-3966. Epub 2011 Sep 6.
2
The inexplicable rise of medication prices.
Ann Clin Psychiatry. 2018 Aug;30(3):165-166.
3
OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Int J Technol Assess Health Care. 2016 Jan;32(6):385-392. doi: 10.1017/S0266462316000623. Epub 2017 Jan 9.
4
Generic Drugs in the United States: Policies to Address Pricing and Competition.
Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10.
5
SaskPharm: a proposal for provincial drug production.
CMAJ. 2011 Jul 12;183(10):1224. doi: 10.1503/cmaj.101814. Epub 2011 May 24.
6
The effect of generic competition on the price of brand-name drugs.
Health Policy. 2004 Apr;68(1):47-54. doi: 10.1016/j.healthpol.2003.07.007.
7
Lowering generic drug prices: less regulation equals more competition.
Med Care. 2003 Jan;41(1):135-41. doi: 10.1097/00005650-200301000-00015.
8
Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries.
Health Aff (Millwood). 2018 Oct;37(10):1578-1586. doi: 10.1377/hlthaff.2018.0628.
9
New generic pricing scheme maintains high prices and risks of shortages.
CMAJ. 2018 Apr 9;190(14):E410-E411. doi: 10.1503/cmaj.180197.
10
Dynamic competition in pharmaceuticals. Patent expiry, generic penetration, and industry structure.
Eur J Health Econ. 2004 Jun;5(2):175-82. doi: 10.1007/s10198-003-0218-x.
引用本文的文献
1
Bias within economic evaluations - the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug.
Clinicoecon Outcomes Res. 2015 Oct 6;7:497-503. doi: 10.2147/CEOR.S90386. eCollection 2015.
2
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.
Pharmacoeconomics. 2014 Sep;32(9):903-17. doi: 10.1007/s40273-014-0173-7.
3
Money left on the table: generic drug prices in Canada.
Healthc Policy. 2013 Feb;8(3):17-25.
Zotero 插件